Related Experiment Video
Updated: Mar 7, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
What people with Down Syndrome can teach us about cardiopulmonary disease
Kelley L Colvin1,2,3, Michael E Yeager4,2,3
1Dept of Bioengineering, University of Colorado Denver, Aurora, CO, USA.
Insights
Individuals with Down syndrome face significant health challenges, including cardiovascular, respiratory, and immune issues. Understanding the genetic basis of these conditions is crucial for developing new treatments and improving quality of life.
Area of Science:
- Genetics
- Immunology
- Cardiology
- Pulmonology
Background:
- Down syndrome, caused by trisomy 21, is the most common chromosomal abnormality in live-born infants.
- It is associated with cognitive impairment, congenital malformations (especially cardiovascular), and dysmorphic features.
- Immune disturbances contribute significantly to the disease burden, including autoimmune conditions and increased susceptibility to infections.
Purpose of the Study:
- To review the cardiovascular, respiratory, and immune challenges in individuals with Down syndrome.
- To explore the genetic underpinnings of these pathobiologies.
- To advocate for comparative studies to advance prevention and treatment strategies.
Main Methods:
- This is a review article, synthesizing existing research on Down syndrome.
- It focuses on summarizing known information regarding cardiovascular, respiratory, and immune system complications.
- Genetic factors contributing to the observed pathologies are discussed.
Main Results:
- Cardiovascular and pulmonary diseases are major causes of mortality, accounting for approximately 75% of deaths in individuals with Down syndrome.
- Immune dysregulation leads to a wide spectrum of health issues, from quality-of-life problems to life-threatening conditions.
- Cognitive impairment and dysmorphic features are characteristic of Down syndrome.
Conclusions:
- Individuals with Down syndrome experience substantial burdens from cardiovascular, respiratory, and immune system disorders.
- Further comparative research on cardiopulmonary diseases in Down syndrome populations is essential.
- Enhanced understanding of genetic factors can drive novel therapeutic and preventative strategies for millions worldwide.
Abstract:
Down syndrome is the most common chromosomal abnormality among live-born infants. Through full or partial trisomy of chromosome 21, Down syndrome is associated with cognitive impairment, congenital malformations (particularly cardiovascular) and dysmorphic features. Immune disturbances in Down syndrome account for an enormous disease burden ranging from quality-of-life issues (autoimmune alopecia) to more serious health issues (autoimmune thyroiditis) and life-threatening issues (leukaemia, respiratory tract infections and pulmonary hypertension). Cardiovascular and pulmonary diseases account for ∼75% of the mortality seen in persons with Down syndrome. This review summarises the cardiovascular, respiratory and immune challenges faced by individuals with Down syndrome, and the genetic underpinnings of their pathobiology. We strongly advocate increased comparative studies of cardiopulmonary disease in persons with and without Down syndrome, as we believe these will lead to new strategies to prevent and treat diseases affecting millions of people worldwide.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Cardiomyopathy I: Introduction and Classification

